Mirae Asset Global ETFs Holdings’s Sana Biotechnology SANA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$374K	Sell	107,424 -36,086	-25%	-$116K	﹤0.01%	2154
2026 Q1	$408K	Buy	143,510 +13,219	+10%	+$52.1K	﹤0.01%	1986
2025 Q4	$530K	Sell	130,291 -34,829	-21%	-$156K	﹤0.01%	1861
2025 Q3	$586K	Buy	165,120 +859	+0.5%	+$3.11K	﹤0.01%	1790
2025 Q2	$448K	Sell	164,261 -108,409	-40%	-$224K	﹤0.01%	1871
2025 Q1	$458K	Sell	272,670 -8,061	-3%	-$22.5K	﹤0.01%	1922
2024 Q4	$457K	Buy	280,731 +6,613	+2%	+$19.7K	﹤0.01%	1961
2024 Q3	$1.14M	Sell	274,118 -18,091	-6%	-$95K	﹤0.01%	1464
2024 Q2	$1.59M	Buy	+292,209	New	+$2.33M	﹤0.01%	1190

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SANA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Sana Biotechnology (SANA) stake by 25% in Q2 2026, selling an estimated $116K and leaving 107,424 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2154.

Mirae Asset Global ETFs Holdings first reported a position in SANA in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.59M in Q2 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Mirae Asset Global ETFs Holdings held 107,424 shares of Sana Biotechnology worth $374K as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 36,086 Sana Biotechnology shares in Q2 2026, an estimated $116K.
Sana Biotechnology made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2154 holding.
Mirae Asset Global ETFs Holdings first reported a position in Sana Biotechnology in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Sana Biotechnology position peaked at $1.59M in Q2 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.